» Articles » PMID: 29270167

Protective Microbiota: From Localized to Long-Reaching Co-Immunity

Overview
Journal Front Immunol
Date 2017 Dec 23
PMID 29270167
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Resident microbiota do not just shape host immunity, they can also contribute to host protection against pathogens and infectious diseases. Previous reviews of the protective roles of the microbiota have focused exclusively on colonization resistance localized within a microenvironment. This review shows that the protection against pathogens also involves the mitigation of pathogenic impact without eliminating the pathogens (i.e., "disease tolerance") and the containment of microorganisms to prevent pathogenic spread. Protective microorganisms can have an impact beyond their niche, interfering with the entry, establishment, growth, and spread of pathogenic microorganisms. More fundamentally, we propose a series of conceptual clarifications in support of the idea of a "co-immunity," where an organism is protected by both its own immune system and components of its microbiota.

Citing Articles

Action and immunomodulatory mechanisms, formulations, and safety concerns of probiotics.

Ashaolu T, Greff B, Varga L Biosci Microbiota Food Health. 2025; 44(1):4-15.

PMID: 39764491 PMC: 11700557. DOI: 10.12938/bmfh.2024-006.


The microbiota: a key regulator of health, productivity, and reproductive success in mammals.

Khan I, Nassar N, Chang H, Khan S, Cheng M, Wang Z Front Microbiol. 2024; 15:1480811.

PMID: 39633815 PMC: 11616035. DOI: 10.3389/fmicb.2024.1480811.


Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions.

Tiwari A, Krisnawati D, Susilowati E, Mutalik C, Kuo T J Agric Food Chem. 2024; 72(50):27679-27700.

PMID: 39588716 PMC: 11660543. DOI: 10.1021/acs.jafc.4c08702.


Microbiome transfer from native to invasive species may increase invasion risk.

Martignoni M, Kolodny O Proc Biol Sci. 2024; 291(2034):20241318.

PMID: 39500380 PMC: 11537765. DOI: 10.1098/rspb.2024.1318.


From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy.

Dora D, Szocs E, Soos A, Halasy V, Somodi C, Mihucz A Front Immunol. 2024; 15:1434804.

PMID: 39301033 PMC: 11410641. DOI: 10.3389/fimmu.2024.1434804.


References
1.
Freter R, Brickner H, Fekete J, Vickerman M, Carey K . Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun. 1983; 39(2):686-703. PMC: 348005. DOI: 10.1128/iai.39.2.686-703.1983. View

2.
Mantis N, Rol N, Corthesy B . Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011; 4(6):603-11. PMC: 3774538. DOI: 10.1038/mi.2011.41. View

3.
Hersoug L, Moller P, Loft S . Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity. Obes Rev. 2015; 17(4):297-312. DOI: 10.1111/obr.12370. View

4.
Mishra C, Lambert J . Production of anti-microbial substances by probiotics. Asia Pac J Clin Nutr. 2014; 5(1):20-4. View

5.
Budden K, Gellatly S, Wood D, Cooper M, Morrison M, Hugenholtz P . Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2016; 15(1):55-63. DOI: 10.1038/nrmicro.2016.142. View